GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Market Cap

Philogen SpA (STU:78Q) Market Cap : €799.82 Mil (As of Apr. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Philogen SpA's share price for the quarter that ended in Jun. 2024 was €19.95. Philogen SpA's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 40.29 Mil. Therefore, Philogen SpA's market cap for the quarter that ended in Jun. 2024 was €803.79 Mil.

Philogen SpA's quarterly market cap increased from Jun. 2023 (€645.76 Mil) to Dec. 2023 (€723.21 Mil) and increased from Dec. 2023 (€723.21 Mil) to Jun. 2024 (€803.79 Mil).

Philogen SpA's annual market cap declined from Dec. 2021 (€573.72 Mil) to Dec. 2022 (€554.49 Mil) but then increased from Dec. 2022 (€554.49 Mil) to Dec. 2023 (€723.21 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Philogen SpA's Enterprise Value for Today is €749.13 Mil.


Philogen SpA Market Cap Historical Data

The historical data trend for Philogen SpA's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Market Cap Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
- 573.72 554.49 723.21 765.45

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only 554.49 645.76 723.21 803.79 765.45

Competitive Comparison of Philogen SpA's Market Cap

For the Biotechnology subindustry, Philogen SpA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Philogen SpA's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's Market Cap distribution charts can be found below:

* The bar in red indicates where Philogen SpA's Market Cap falls into.


;
;

Philogen SpA Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Philogen SpA's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€17.95*40.290
=€723.21

Philogen SpA's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=€19.95*40.290
=€803.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Philogen SpA  (STU:78Q) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Philogen SpA Market Cap Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines